EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Soluble receptors for advanced glycation endproducts are predictors of insulin sensitivity and affected by weight loss

José María Moreno-Navarrete iD, Yenny Leal, Marisel Rosell-Díaz, José Manuel Fernández-Real

Nutrition & Diabetes · 2024

DOI: 10.1038/s41387-024-00345-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition & Diabetes, 2024. Verfasst von José María Moreno-Navarrete und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition, Eumetabolism and Health Group, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), Av. França 30, 17007, Girona, Spain. jmoreno@id…. Hauptthemen laut MEDLINE: Insulin Resistance, Weight Loss, Receptor for Advanced Glycation End Products, Obesity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mice experiments have underscored the efficacy of pharmacological inhibition of advanced glycation endproducts (AGEs) through the use of soluble receptors for advanced glycation endproducts (sRAGE) in mitigating obesity-linked metabolic disruptions and insulin resistance. However, human studies have presented conflicting findings regarding the correlation between circulating sRAGE levels and insulin resistance, as well as glucose tolerance. Here, we aimed to delve deeper into the relationship between sRAGE levels and systemic insulin sensitivity. METHODS: Plasma sRAGE levels, hyperinsulinemic-euglycemic clamp, and continuous glucose monitoring were measured in two independent cross-sectional case-control studies [cohort 1 (n = 180) and cohort 2 (n = 124)]. In addition, a subgroup of 42 participants with obesity were followed for 12 months. In 14 of these participants, weight loss was achieved through bariatric surgery intervention. RESULTS: Our results revealed a significant association between plasma sRAGE levels and both insulin sensitivity and glycemic control parameters, even after adjustments for age, sex, and BMI. Furthermore, longitudinal analysis demonstrated that interventions aimed at weight loss led to reductions in fasting glucose and HbA1c levels, concurrently with increases in sRAGE levels. CONCLUSIONS: These findings underscore that sRAGE levels were strongly associated with insulin sensitivity and glycemic control, suggesting a possible role of sRAGE in preserving insulin sensitivity and maintaining glycemic control, which should be confirmed in further studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceWeight LossReceptor for Advanced Glycation End ProductsObesityBlood GlucoseHumansMaleFemaleCross-Sectional StudiesMiddle AgedAdultCase-Control StudiesGlucose Clamp TechniqueGlycated HemoglobinBariatric SurgeryBody Mass Index

Substanzen

Receptor for Advanced Glycation End ProductsBlood GlucoseGlycated Hemoglobin

Autor:innen und Institutionen

  • Nutrition, Eumetabolism and Health Group, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), Av. França 30, 17007, Girona, Spain. jmoreno@idibgi.org.
  • CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029, Madrid, Spain. jmoreno@idibgi.org.
  • Department of Medical Sciences, School of Medicine, University of Girona, 17003, Girona, Spain. jmoreno@idibgi.org.
  • Nutrition, Eumetabolism and Health Group, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), Av. França 30, 17007, Girona, Spain.
  • CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029, Madrid, Spain.
  • Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Av. França, s/n, 17007, Girona, Spain.

ORCID-Profile: José María Moreno-Navarrete

Förderung

  • Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III)

Zitieren

APA

Moreno-Navarrete, J. M., Leal, Y., Rosell-Díaz, M., & Fernández-Real, J. M. (2024). Soluble receptors for advanced glycation endproducts are predictors of insulin sensitivity and affected by weight loss. Nutrition & Diabetes. https://doi.org/10.1038/s41387-024-00345-8

Vancouver

Moreno-Navarrete JM, Leal Y, Rosell-Díaz M, Fernández-Real JM. Soluble receptors for advanced glycation endproducts are predictors of insulin sensitivity and affected by weight loss. Nutrition & Diabetes. 2024. doi:10.1038/s41387-024-00345-8

BibTeX
@article{MorenoNavarrete2024,
  author = {Moreno-Navarrete, José María and Leal, Yenny and Rosell-Díaz, Marisel and Fernández-Real, José Manuel},
  title = {Soluble receptors for advanced glycation endproducts are predictors of insulin sensitivity and affected by weight loss},
  journal = {Nutrition & Diabetes},
  year = {2024},
  doi = {10.1038/s41387-024-00345-8}
}
Kostenlos starten →